Clinical Trial: Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neuroendocrine Tumors
Study Type: INTERVENTIONAL
Official Title: A Phase I/IIa First-in-Human Study of [212Pb]VMT-?-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Brief Summary:
This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-?-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Read more